Edition:
United Kingdom

Biocon Ltd (BION.NS)

BION.NS on National Stock Exchange of India

615.25INR
15 Feb 2019
Change (% chg)

Rs-26.60 (-4.14%)
Prev Close
Rs641.85
Open
Rs639.90
Day's High
Rs642.00
Day's Low
Rs610.85
Volume
1,454,160
Avg. Vol
1,888,636
52-wk High
Rs718.00
52-wk Low
Rs543.30

Chart for

About

Biocon Limited is a biopharmaceutical company. The Company focuses to reduce therapy costs of chronic diseases like autoimmune, diabetes, and cancer. Through its products and research services it is enabling access to affordable healthcare for patients, partners and healthcare systems across the globe. The Company has developed... (more)
No analyst recommendations are available for .

Overall

No Ratios Available.

Financials

  BION.NS Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -- -- --
ROI: -- 8.92 14.45
ROE: -- 10.08 15.96

India's Biocon quarterly profit more than doubles, beats estimate

Jan 24 Indian biotechnology firm Biocon Ltd's quarterly profit more than doubled, handily beating analysts' estimates, largely driven by strong performance of its biologics businesses.

24 Jan 2019

CORRECTED-India's Biocon Q2 profit surges on one-off gain

Oct 25 Indian biotechnology company Biocon Ltd posted an over five-fold rise in second-quarter profit on Thursday, as the company recorded a one-off gain of 1.89 billion rupees ($25.79 million).

25 Oct 2018

Earnings vs. Estimates

No consensus analysis data available.